The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Factors associated with successful response to neurolytic celiac plexus block in patients with upper abdominal cancer-related pain: a retrospective study

  • Kwon, Hyun-Jung (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Jang, Kyunghwan (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Leem, Jeong-Gil (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Shin, Jin-Woo (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Doo-Hwan (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Seong-Soo (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2021.04.19
  • Accepted : 2021.07.13
  • Published : 2021.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Prior studies have reported that 40%-90% of the patients with celiac plexus-mediated visceral pain benefit from the neurolytic celiac plexus block (NCPB), but the predictive factors of response to NCPB have not been evaluated extensively. This study aimed to identify the factors associated with the immediate analgesic effectiveness of NCPB in patients with intractable upper abdominal cancer-related pain. Methods: A retrospective review was performed of 513 patients who underwent NCPB for upper abdominal cancer-related pain. Response to the procedure was defined as (1) a decrease of ≥ 50% or ≥ 4 points on the numerical rating scale (NRS) in pain intensity from the baseline without an increase in opioid requirement, or (2) a decrease of ≥ 30% or ≥ 2 points on the NRS from the baseline with simultaneously reduced opioid consumption after NCPB. Logistic regression analysis was performed to determine the factors associated with successful responses to NCPB. Results: Among the 513 patients included in the analysis, 255 (49.8%) and 258 (50.2%) patients were in the non-responder and responder group after NCPB, respectively. Multivariable logistic regression analysis showed that diabetes (odds ratio [OR] = 0.644, P = 0.035), history of upper abdominal surgery (OR = 0.691, P = 0.040), and celiac metastasis (OR = 1.496, P = 0.039) were the independent factors associated with response to NCPB. Conclusions: Celiac plexus metastases, absence of diabetes, and absence of prior upper abdominal surgery may be independently associated with better response to NCPB for upper abdominal cancer-related pain.

Keywords

Acknowledgement

The authors thank the residents and clinical fellows in the Department of Anesthesiology and Pain Medicine, Asan Medical Center for collecting data in the present study (Drs. Hanwool Park, Chan-Sik Kim, Sooin Park, and Yul Oh).

References

  1. van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage 2016; 51: 1070-90.e9. https://doi.org/10.1016/j.jpainsymman.2015.12.340
  2. de Oliveira R, dos Reis MP, Prado WA. The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain 2004; 110: 400-8. https://doi.org/10.1016/j.pain.2004.04.023
  3. Si-Jie H, Wei-Jia X, Yang D, Lie Y, Feng Y, Yong-Jian J, et al. How to improve the efficacy of endoscopic ultrasound-guided celiac plexus neurolysis in pain management in patients with pancreatic cancer: analysis in a single center. Surg Laparosc Endosc Percutan Tech 2014; 24: 31-5. https://doi.org/10.1097/SLE.0000000000000032
  4. Sachdev AH, Gress FG. Celiac plexus block and neurolysis: a review. Gastrointest Endosc Clin N Am 2018; 28: 579-86. https://doi.org/10.1016/j.giec.2018.06.004
  5. Ischia S, Ischia A, Polati E, Finco G. Three posterior percutaneous celiac plexus block techniques. A prospective, randomized study in 61 patients with pancreatic cancer pain. Anesthesiology 1992; 76: 534-40. https://doi.org/10.1097/00000542-199204000-00008
  6. Edelstein MR, Gabriel RT, Elbich JD, Wolfe LG, Sydnor MK. Pain outcomes in patients undergoing CT-guided celiac plexus neurolysis for intractable abdominal visceral pain. Am J Hosp Palliat Care 2017; 34: 111-4. https://doi.org/10.1177/1049909115604670
  7. Rykowski JJ, Hilgier M. Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: influence on pain relief. Anesthesiology 2000; 92: 347-54. https://doi.org/10.1097/00000542-200002000-00014
  8. Wong GY, Schroeder DR, Carns PE, Wilson JL, Martin DP, Kinney MO, et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 2004; 291: 1092-9. https://doi.org/10.1001/jama.291.9.1092
  9. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg 1995; 80: 290-5. https://doi.org/10.1213/00000539-199502000-00015
  10. Koyyalagunta D, Engle MP, Yu J, Feng L, Novy DM. The effectiveness of alcohol versus phenol based splanchnic nerve neurolysis for the treatment of intra-abdominal cancer pain. Pain Physician 2016; 19: 281-92. https://doi.org/10.36076/ppj/2019.19.281
  11. Mercadante S, Catala E, Arcuri E, Casuccio A. Celiac plexus block for pancreatic cancer pain: factors influencing pain, symptoms and quality of life. J Pain Symptom Manage 2003; 26: 1140-7. https://doi.org/10.1016/j.jpainsymman.2003.04.004
  12. Yoon DM, Yoon KB, Baek IC, Ko SH, Kim SH. Predictors of analgesic efficacy of neurolytic celiac plexus block in patients with unresectable pancreatic cancer: the importance of timing. Support Care Cancer 2018; 26: 2023-30. https://doi.org/10.1007/s00520-018-4043-2
  13. De Cicco M, Matovic M, Bortolussi R, Coran F, Fantin D, Fabiani F, et al. Celiac plexus block: injectate spread and pain relief in patients with regional anatomic distortions. Anesthesiology 2001; 94: 561-5. https://doi.org/10.1097/00000542-200104000-00006
  14. Wyse JM, Carone M, Paquin SC, Usatii M, Sahai AV. Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol 2011; 29: 3541-6. https://doi.org/10.1200/JCO.2010.32.2750
  15. Luz LP, Al-Haddad MA, DeWitt JA. EUS-guided celiac plexus interventions in pancreatic cancer pain: an update and controversies for the endosonographer. Endosc Ultrasound 2014; 3: 213-20. https://doi.org/10.4103/2303-9027.144515
  16. Lu F, Dong J, Tang Y, Huang H, Liu H, Song L, et al. Bilateral vs. unilateral endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain management in patients with pancreatic malignancy: a systematic review and meta-analysis. Support Care Cancer 2018; 26: 353-9. https://doi.org/10.1007/s00520-017-3888-0
  17. Yoon WJ, Oh Y, Yoo C, Jang S, Cho SS, Suh JH, et al. EUS-guided versus percutaneous celiac neurolysis for the management of intractable pain due to unresectable pancreatic cancer: a randomized clinical trial. J Clin Med 2020; 9: 1666. https://doi.org/10.3390/jcm9061666
  18. Kong YG, Shin JW, Leem JG, Suh JH. Computed tomography (CT) simulated fluoroscopy-guided transdiscal approach in transcrural celiac plexus block. Korean J Pain 2013; 26: 396-400. https://doi.org/10.3344/kjp.2013.26.4.396
  19. Vissers KC, Besse K, Wagemans M, Zuurmond W, Giezeman MJ, Lataster A, et al. 23. Pain in patients with cancer. Pain Pract 2011; 11: 453-75. https://doi.org/10.1111/j.1533-2500.2011.00473.x
  20. Kambadakone A, Thabet A, Gervais DA, Mueller PR, Arellano RS. CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics 2011; 31: 1599-621. https://doi.org/10.1148/rg.316115526
  21. Kahan M, Mailis-Gagnon A, Wilson L, Srivastava A. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population. Can Fam Physician 2011; 57: 1257-66, e407-18.
  22. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008; 9: 105-21. https://doi.org/10.1016/j.jpain.2007.09.005
  23. Hameed M, Hameed H, Erdek M. Pain management in pancreatic cancer. Cancers (Basel) 2010; 3: 43-60. https://doi.org/10.3390/cancers3010043
  24. Nagels W, Pease N, Bekkering G, Cools F, Dobbels P. Celiac plexus neurolysis for abdominal cancer pain: a systematic review. Pain Med 2013; 14: 1140-63. https://doi.org/10.1111/pme.12176
  25. Polati E, Finco G, Gottin L, Bassi C, Pederzoli P, Ischia S. Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. Br J Surg 1998; 85: 199-201. https://doi.org/10.1046/j.1365-2168.1998.00563.x
  26. Kawamata M, Ishitani K, Ishikawa K, Sasaki H, Ota K, Omote K, et al. Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain. Pain 1996; 64: 597-602. https://doi.org/10.1016/0304-3959(95)00189-1
  27. Amr YM, Makharita MY. Comparative study between 2 protocols for management of severe pain in patients with unresectable pancreatic cancer: one-year follow-up. Clin J Pain 2013; 29: 807-13. https://doi.org/10.1097/AJP.0b013e3182757673
  28. Erdek MA, Halpert DE, Gonzalez Fernandez M, Cohen SP. Assessment of celiac plexus block and neurolysis outcomes and technique in the management of refractory visceral cancer pain. Pain Med 2010; 11: 92-100. https://doi.org/10.1111/j.1526-4637.2009.00756.x
  29. Bahn BM, Erdek MA. Celiac plexus block and neurolysis for pancreatic cancer. Curr Pain Headache Rep 2013; 17: 310. https://doi.org/10.1007/s11916-012-0310-y
  30. Titton RL, Lucey BC, Gervais DA, Boland GW, Mueller PR. Celiac plexus block: a palliative tool underused by radiologists. AJR Am J Roentgenol 2002; 179: 633-6. https://doi.org/10.2214/ajr.179.3.1790633
  31. Mercadante S, Nicosia F. Celiac plexus block: a reappraisal. Reg Anesth Pain Med 1998; 23: 37-48.
  32. Kim SH, Hwang JH. Preoperative glycosylated haemoglobin as a predictor of postoperative analgesic requirements in diabetic patients: a prospective observational study. Eur J Anaesthesiol 2015; 32: 705-11. https://doi.org/10.1097/EJA.0000000000000282
  33. Choi SS, Lee JH, Kim D, Kim HK, Lee S, Song KJ, et al. Effectiveness and factors associated with epidural decompression and adhesiolysis using a balloon-inflatable catheter in chronic lumbar spinal stenosis: 1-year follow-up. Pain Med 2016; 17: 476-87. https://doi.org/10.1093/pm/pnv018
  34. Borsook D, Kussman BD, George E, Becerra LR, Burke DW. Surgically induced neuropathic pain: understanding the perioperative process. Ann Surg 2013; 257: 403-12. https://doi.org/10.1097/SLA.0b013e3182701a7b
  35. Sweetser S. Abdominal wall pain: a common clinical problem. Mayo Clin Proc 2019; 94: 347-55. https://doi.org/10.1016/j.mayocp.2018.04.031
  36. Akhan O, Ozmen MN, Basgun N, Akinci D, Oguz O, Koroglu M, et al. Long-term results of celiac Ganglia block: correlation of grade of tumoral invasion and pain relief. AJR Am J Roentgenol 2004; 182: 891-6. https://doi.org/10.2214/ajr.182.4.1820891
  37. Iwata K, Yasuda I, Enya M, Mukai T, Nakashima M, Doi S, et al. Predictive factors for pain relief after endoscopic ultrasound-guided celiac plexus neurolysis. Dig Endosc 2011; 23: 140-5.
  38. Levy MJ, Topazian M, Keeney G, Clain JE, Gleeson F, Rajan E, et al. Preoperative diagnosis of extrapancreatic neural invasion in pancreatic cancer. Clin Gastroenterol Hepatol 2006; 4: 1479-82. https://doi.org/10.1016/j.cgh.2006.08.012